| RS2100841033 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2100842233 |
CHD5
|
Health Risk |
Likely pathogenic |
Global developmental delay, Seizure |
| RS2100843378 |
CHD5
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2100843382 |
CHD5
|
Health Risk |
Pathogenic/Likely pathogenic |
Global developmental delay, Intellectual disability |
| RS2100844517 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2100844690 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 2 |
| RS2100846484 |
CHD5
|
Health Risk |
Likely pathogenic |
Seizure, Parenti-mignot neurodevelopmental syndrome |
| RS2100847449 |
CHD5
|
Health Risk |
Pathogenic/Likely pathogenic |
Global developmental delay, Seizure |
| RS2100849117 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2100849229 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2100849251 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2100851333 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2100851477 |
CHD5
|
Health Risk |
Likely pathogenic |
— |
| RS2100852410 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2100852418 |
COL11A1
|
Health Risk |
Pathogenic |
Marshall syndrome, Stickler syndrome type 2 |
| RS2100852782 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2100853005 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2100853065 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2100854670 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2100856157 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Inborn genetic diseases |
| RS2100858186 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2A2 |
| RS2100858599 |
GNB1
|
Health Risk |
Pathogenic |
— |
| RS2100858748 |
GNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 42 |
| RS2100860639 |
CHD5
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2100863089 |
CHD5
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2100864027 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2100867585 |
MASP2
|
Health Risk |
Likely pathogenic |
— |
| RS2100868745 |
CHD5
|
Health Risk |
Likely pathogenic |
Global developmental delay, Seizure |
| RS2100869173 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2100872124 |
GLMN
|
Health Risk |
Pathogenic |
Glomuvenous malformation, Inborn genetic diseases |
| RS2100872719 |
CDC14A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 32, Autosomal recessive nonsyndromic hearing loss 32 |
| RS2100876312 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2100876453 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2100901805 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
| RS2100903095 |
GLMN
|
Health Risk |
Pathogenic |
— |
| RS2100916221 |
SKI
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2100916637 |
GLMN
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, Vascular skin disorders |
| RS2100921727 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2100922903 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2100925460 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2100932956 |
LEPR
|
Health Risk |
Likely pathogenic |
Early onset severe obesity, Early onset severe obesity |
| RS2100949783 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated developmental and epileptic encephalopathy, KCNA3-associated developmental and epileptic encephalopathy |
| RS2100954909 |
PIK3CD
|
Health Risk |
Likely pathogenic |
Immunodeficiency 14, Immunodeficiency 14 |
| RS2100954945 |
PIK3CD
|
Health Risk |
Likely pathogenic |
Immunodeficiency 14, Immunodeficiency 14 |
| RS2100956273 |
PIK3CD
|
Health Risk |
Pathogenic |
Immunodeficiency 14b, autosomal recessive |
| RS2100972370 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2100972539 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2100976217 |
PIK3CD
|
Health Risk |
Pathogenic |
Combined immunodeficiency with faciooculoskeletal anomalies, Combined immunodeficiency with faciooculoskeletal anomalies |
| RS2100982320 |
PGM1
|
Health Risk |
Pathogenic |
PGM1-congenital disorder of glycosylation, PGM1-congenital disorder of glycosylation |
| RS2100983961 |
MTOR
|
Health Risk |
Pathogenic |
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
| RS2100987881 |
ABCA4
|
Health Risk |
Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS2100987980 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2100988221 |
ABCA4
|
Health Risk |
Pathogenic |
ABCA4-related retinopathy, ABCA4-related retinopathy |
| RS2100988422 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2100988650 |
PGM1
|
Health Risk |
Pathogenic |
PGM1-congenital disorder of glycosylation, PGM1-congenital disorder of glycosylation |
| RS2100990445 |
PIK3CD
|
Health Risk |
Pathogenic |
Immunodeficiency 14b, autosomal recessive |
| RS2100991976 |
GNB1
|
Health Risk |
Pathogenic |
— |
| RS2100992189 |
AP4B1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2100993446 |
B3GALT6
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, spondylodysplastic type |
| RS2100993531 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2100993760 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2100993895 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 2, Severe early-childhood-onset retinal dystrophy |
| RS2100994047 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2100994049 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-childhood-onset retinal dystrophy, Stargardt disease |
| RS2100994077 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-childhood-onset retinal dystrophy, ABCA4-related disorder |
| RS2100994099 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2100994885 |
AP4B1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2100995157 |
AP4B1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2100995699 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2100996308 |
HENMT1
|
Health Risk |
Pathogenic |
Azoospermia, Azoospermia |
| RS2100997427 |
AP4B1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2100998416 |
AP4B1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2101000353 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101000357 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101000542 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101000596 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS2101000962 |
DRAM2
|
Health Risk |
Pathogenic |
— |
| RS2101003223 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101003323 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101003456 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101004096 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101004195 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101005282 |
DRAM2
|
Health Risk |
Pathogenic |
— |
| RS2101005817 |
CSDE1
|
Health Risk |
Pathogenic |
— |
| RS2101007411 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101007419 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101007643 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101008251 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101008373 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-childhood-onset retinal dystrophy, Cone-rod dystrophy 3 |
| RS2101008577 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS2101008674 |
TSHB
|
Health Risk |
Likely pathogenic |
Isolated thyroid-stimulating hormone deficiency, Isolated thyroid-stimulating hormone deficiency |
| RS2101013633 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS2101013784 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101013876 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101015147 |
AP4B1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 47, Spastic paraplegia |
| RS2101015376 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101015583 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101017052 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2101017789 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2101018240 |
NGF
|
Health Risk |
Pathogenic |
Congenital sensory neuropathy with selective loss of small myelinated fibers, Peripheral neuropathy |